A citation-based method for searching scientific literature

Mark G Kris, Bruce E Johnson, Lynne D Berry, David J Kwiatkowski, A John Iafrate, Ignacio I Wistuba, Marileila Varella-Garcia, Wilbur A Franklin, Samuel L Aronson, Pei-Fang Su, Yu Shyr, D Ross Camidge, Lecia V Sequist, Bonnie S Glisson, Fadlo R Khuri, Edward B Garon, William Pao, Charles Rudin, Joan Schiller, Eric B Haura, Mark Socinski, Keisuke Shirai, Heidi Chen, Giuseppe Giaccone, Marc Ladanyi, Kelly Kugler, John D Minna, Paul A Bunn. JAMA 2014
Times Cited: 955



Achim Rittmeyer, Fabrice Barlesi, Daniel Waterkamp, Keunchil Park, Fortunato Ciardiello, Joachim von Pawel, Shirish M Gadgeel, Toyoaki Hida, Dariusz M Kowalski, Manuel Cobo Dols, Diego L Cortinovis, Joseph Leach, Jonathan Polikoff, Carlos Barrios, Fairooz Kabbinavar, Osvaldo ArĂ©n Frontera, Filippo De Marinis, Hande Turna, Jong-Seok Lee, Marcus Ballinger, Marcin Kowanetz, Pei He, Daniel S Chen, Alan Sandler, David R Gandara. Lancet 2017
Times Cited: 2364




List of shared articles



Times cited

2020 Innovation-Based Optimism for Lung Cancer Outcomes.
Erin L Schenk, Tejas Patil, Jose Pacheco, Paul A Bunn. Oncologist 2021
1

Institutional-Level Differences in Quality and Outcomes of Lung Cancer Resections in the United States.
Raymond U Osarogiagbon, Helmneh M Sineshaw, Chun Chieh Lin, Ahmedin Jemal. Chest 2021
3

Emerging biomarkers for neoadjuvant immune checkpoint inhibitors in operable non-small cell lung cancer.
Monika Pradhan, Mathieu Chocry, Don L Gibbons, Boris Sepesi, Tina Cascone. Transl Lung Cancer Res 2021
4

Efficacy of Combination Docetaxel and Nintedanib in Advanced Non-Small Cell Lung Cancer in Thailand: A Multicenter Study.
Krittiya Korphaisarn, Pongwut Danchaivijitr, Thanyanan Reungwetwattana, Busayamas Chewaskulyong, Luangyot Thongthieang, Jarin Chindaprasirt, Kunlatida Maneenil, Chirawadee Sathitruangsak, Chanida Vinayanuwattikun. Front Oncol 2021
2

Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC.
Michael J Grant, Roy S Herbst, Sarah B Goldberg. Nat Rev Clin Oncol 2021
2

Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysis.
Giorgia Guaitoli, Marcello Tiseo, Massimo Di Maio, Luc Friboulet, Francesco Facchinetti. Transl Lung Cancer Res 2021
1

Comprehensive assessment of PD-L1 expression, tumor mutational burden and oncogenic driver alterations in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Kiyotaka Yoh, Shingo Matsumoto, Naoki Furuya, Kazumi Nishino, Shingo Miyamoto, Satoshi Oizumi, Norio Okamoto, Hidetoshi Itani, Shoichi Kuyama, Atsushi Nakamura,[...]. Lung Cancer 2021
0

Clinical Efficacy and Future Prospects of Immunotherapy in Lung Cancer.
Tomonari Kinoshita, Hideki Terai, Tomonori Yaguchi. Life (Basel) 2021
0

The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC).
Ravi Salgia, Rebecca Pharaon, Isa Mambetsariev, Arin Nam, Martin Sattler. Cell Rep Med 2021
3

Paradigm shift in the management of metastatic nonsmall cell lung cancer.
Ruby Gupta, Melanie Smalley, Nwabundo Anusim, Vishal Jindal, Mandeep Singh Rahi, Sorab Gupta, Sachin Gupta, Ishmael Jaiyesimi. Int J Clin Pract 2021
0